Pfizer takes its shot at a vaccine for evasive superbug
More patients than docs report skin surgery problems By Genevra Pittman NEW YORK (Reuters Health) - More than one quarter of people being treated for non-melanoma skin cancer in their doctor's office reported some type of complication after surgery, in a new study. About half of those complications were medical problems related to the cancer-removing procedure, including pain, infections and slow wou...... Thrifty Merrimack developing new cancer drugs at lower cost By Bill Berkrot NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of the cost spent by larger rivals. That could translate into lower-cost treatments for large unmet needs, such as pancreatic cancer, at prec...... Helen Mirren Fulfills Boy?s Dying Wish When Real Queen Says No A little boy's dying wish came true, thanks to Dame Helen Mirren. Oliver Burton is a 10-year-old boy with Down syndrome who has fought different forms of cancer for nearly his entire life. He was recently diagnosed with terminal spine and bone marrow cancer. Oliver requested to visit Buckingham Palace and have afternoon tea with [...] Oncolytics rises on melanoma study results Shares of Oncolytics Biotech Inc. rose Wednesday after the company reported promising results for its drug Reolysin as a treatment for melanoma, the deadliest form of skin cancer. Oncolytics said it is ... Cancer Society hits 100 as US cancer rate falls
Oncolytics cancer drug meets mid-stage trial goal, shares rise (Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer. Shares of the Calgary-based company rose as much as 11 percent to C$3.14 on the Toronto Stock Exchange on Wednesday. Its ...... Ahead of the Bell: Analyst upgrades Bristol-Myers Bristol-Myers Squibb could be a big winner with a portfolio of cancer treatments under development that use a patient's own immune system to attack the disease, according to a Citi, which raised its rating ... Sisters ejected from Pa. mall over cancer hats KING OF PRUSSIA, Pa. (AP) ? Three sisters say they were kicked out of a suburban Philadelphia mall after refusing to remove profanity-laden hats expressing their hatred of breast cancer. You can save this news page by submitting it to your favorite sites:
All News Lines - Local and World Wide, Updated Hourly
|
| ||||||||||||||||||||||
|
||||||||||||||||||||||
| ||||||||||||||||||||||
|
By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine success could come by taming......
The American Cancer Society ? one of the nation's best known and influential health advocacy groups ? is 100 years old this week. Back in 1913 when it was formed, cancer was a lesser threat for most Americans. ...
